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ABSTRACT 
Yves Maurice Morillon II: Thymic development of autoreactive T cells in NOD mice, and 
the altered trafficking of T cells following antibody mediated crosslinking of the CD4 
coreceptor 
(Under the direction of Roland Tisch) 
 
Two key processes in driving type 1 diabetes are the development and trafficking of  
cell-specific T cells into the pancreas. The first part of this dissertation examines thymic 
development of autoreactive T cells, whereas the second part explores novel T cell 
trafficking pathways upon antibody binding to CD4. 
The production of autoreactive T cells occurs through a failure of negative selection 
in the thymus. We utilized a thymic transplant approach to investigate possible ontogenic 
changes in autoreactive T cell production. Various aged NOD thymi were transplanted into 
NOD.scid recipients, which were then assessed for pathology. The development of diabetes 
was restricted to recipients of newborn thymi, insulitis was observed in recipients of 7 and 10 
day, but not older thymi. Increased diabetes and insulitis was associated with increased 
diabetogenic T effectors and not with altered regulatory T cell frequency or activity. In 
contrast, recipients of older thymi developed colitis, characterized by IFNand IL-17 
producing T cells reactive to gut microbiota. These findings demonstrate that thymic 
development of autoreactive T cells is restricted to a narrow window, and that the efficacy of 
thymic negative and positive selection increases with age in mice. 
T cell migration is a highly controlled process of adaptive immunity. Defects in 
trafficking can result in inappropriate immune responses, including autoimmunity. We 
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recently reported diabetes remission in NOD mice following administration of anti-CD4 and 
anti-CD8 antibodies. Remission was associated with T cell purging from the pancreas and 
pancreatic lymph nodes. In this study, we investigated the mechanisms of purging following 
anti-CD4 treatment. Shortly after anti-CD4 treatment, the activity of the GTPases Rac1 and 
Rac2 were markedly increased. Notably, Rac1 and Rac2 function are associated with T cell 
migration. In addition, T cell polarization was increased, and expression of lymph node 
homing adhesion molecules were decreased, concomitant with T cell egress from the 
pancreatic lymph nodes. Furthermore pancreatic lymph node but not splenic T cells isolated 
from anti-CD4 treated mice exhibited increased in vitro chemotaxis to tested chemokines. 
These findings demonstrate that crosslinking of CD4 induces a pro-migratory phenotype via 
a novel Rac associated pathway in T cells.  
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Chapter 1: Background and Significance 
 
Etiology of Type 1 Diabetes  
Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of 
insulin producing  cells located in the islets of Langerhans of the pancreas (1, 2). Clinical 
disease, as defined by an inability to regulate blood glucose levels, develops once 
approximately 85-90% of  cell mass has been destroyed or rendered nonfunctional. The 
initiating events in the development of T1D are unknown; however, both genetic and 
epigenetic/environmental factors play a role. Susceptibility to T1D is associated with a 
number of genes (3) with greatest risk in humans linked to genes encoding specific alleles of 
human leukocyte antigen class II molecules (4). Ill-defined environmental factors also play a 
role, which is most popularly described using the “Hygiene hypothesis”, where “cleaner” 
environments and better hygiene are associated with increased incidence of T1D, as well as a 
reduction in disease in less developed and less hygienic regions (5).   
T1D is mediated by several immune effector cell types (6-8). Experimentally, 
nonobese diabetic (NOD) mice lacking either CD4+ or CD8+ T cells fail to develop 
spontaneous T1D (6). Indirect evidence also suggests a key role for CD4+ and CD8+ T cells 
in human T1D; for instance both cell types are found infiltrating the islets of pancreata from 
T1D patients, with CD8+ T cells being the most abundant (7).  
In order for autoreactive T cells to mediate pathogenic activity, they must first be 
primed via their interaction with antigen presenting cells (APC), such as B cells, 
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macrophages, and dendritic cells (DC). Macrophages, DC, and B cells are among the first 
adaptive immune cells to enter the islets (8). The importance of B cells in T1D pathogenesis 
is evident in NOD MT-/- mice, which lack B cells, and do not develop diabetes (9). Certain 
B cell subsets are suggested to be important in disease development, although studies have 
correlated increased subset presence with onset of disease (10), no studies report an absolute 
requirement for a particular subset. Although  cell-specific autoantibodies are detected and 
remain an indicator of T1D in both mice and humans, the necessity of autoantibodies in 
disease progression has yet to be demonstrated. It is therefore believed that B cells serve as a 
critical APC (11), directing autoantigen presentation through recognition of a self-reactive 
monoclonal B cell receptor. This idea is supported by depleting B cells in NOD mice using 
an anti-CD20 therapy (12). Transiently depleting B cells significantly delays or protects from 
diabetes onset. 
Ultimately, it is autoreactive T cells, which have escaped mechanisms of both central 
and peripheral tolerance which carry out the final destruction of  cells. Investigations have 
described a genetic defect in negative selection of autoreactive T cells in NOD animals (13, 
14). Thymocytes in NOD versus non-autoimmune strains of mice have been shown to be 
more resistant to apoptotic signals during negative selection (13, 15). Although we will 
provide a more in depth description below, briefly, thymic selection is comprised of positive 
and negative selection events (16). Positive selection insures that mature T cells are able to 
interact with self major histocompatibility complex (MHC) molecules, whereas negative 
selection results in the elimination of autoreactive T cells but can also lead to the generation 
of Foxp3 expressing CD4+ regulatory T cells (Foxp3+Treg). In a non-autoimmune prone 
environment, some degree of autoreactive T cell escape occurs, however, mechanisms of 
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peripheral tolerance, in part mediated by CD4+ Treg, prevent the development of a 
pathological autoimmune response. A reduction in Treg frequency and/or function is 
believed to result in preferential differentiation and expansion of pathogenic  cell-specific 
CD4+ and CD8+ T cells, typically exhibiting a type 1 phenotype marked by IFN secretion 
(17).  
In the event that autoimmune T cells escape mechanisms of central and peripheral 
tolerance, they must be primed by autoantigen expressing APC. Once activated, T cells exit 
the lymph nodes and enter into the target tissue. In the case of T1D, the draining pancreatic 
lymph nodes (PLN) are the key site for  cell-specific T cell activation, expansion and 
differentiation prior to trafficking into the pancreas (18). Once in the islets, established T 
effectors encounter cognate antigen to drive  cell destruction.  
This thesis will concentrate on two distinct aspects of T1D. In Chapter 2, we focus on 
central tolerance and provide evidence that the efficacy of thymic negative selection is 
regulated in a temporal manner. In Chapter 3, we investigate the mechanisms by which an 
antibody-mediated T cell coreceptor-based immunotherapy affects the trafficking properties 
of  cell-specific T cells.  
Thymic Selection and Central Tolerance  
Thymic development of thymocytes entails a number of selection events that results 
in the production of mature T cells that mediate protection against pathogens, and which do 
not elicit a pathological response to self-antigens. Hematopoietic-derived T cell precursors 
arrive in the thymus lacking expression of the T cell receptor (TCR) and the CD4 and CD8 
coreceptor molecules (19). These double negative (DN) thymocytes interact with cortical 
thymic epithelial cells (cTEC) resulting in upregulation of the recombinase activating gene 
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(RAG) and expression of a functional in frame TCR variable (V) chain (20). Only DN 
thymocytes that successfully produce a pre-TCR complex, a V chain with an invariant 
surrogate V chain, continue on to the double positive (DP) thymocyte stage (21, 22). DP 
thymocytes must first rearrange a functional V chain in order to express an  TCR. DP 
thymocytes also characteristically express both CD4 and CD8. It is at this stage, that DP 
thymocytes undergo positive selection in which survival relies on the successful TCR 
recognition of MHC class I and II expressed by cTEC. In the absence of TCR signals 
generated upon appropriate MHC class I and II binding, DP thymocytes undergo apoptosis 
by “neglect”. Attrition is high since only 3-5% of thymocytes successfully progress past the 
DP stage (23).  
Successful completion of positive selection results in migration from the thymic 
cortex to the medulla, where DP thymocytes mature to become single positive (SP) 
thymocytes, expressing either the CD4 or CD8 receptor. SP thymocytes undergo negative 
selection via interactions with medullary thymic epithelial cells (mTEC) and thymic DC. 
Notably, mTEC via the autoimmune regulator (AIRE) transcription factor express a 
multitude of self-antigens normally expressed in the periphery (24). A pivotal role for AIRE 
was demonstrated in mice deficient of the transcription factor. AIRE
null
 mice develop a T cell 
mediated systemic multi-organ autoimmune disease. Notably, similar pathology is seen in 
patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) 
(25, 26) which is marked by mutations in the AIRE gene. Not all self-antigens are presented 
by mTEC in an AIRE-dependent manner. For instance “migratory” DC trafficking into the 
thymic medulla can present self-antigens that had earlier been endocytosed in the periphery 
(27, 28). Thymic DC may also capture blood borne self-antigens.    
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Thymic negative selection relies on the affinity/avidity of TCR recognition of the 
self-antigen peptide-MHC complex; increased binding promotes apoptosis and purging of the 
TCR repertoire (29). Alternatively, interactions with increased affinity/avidity may promote 
development of Foxp3+Treg (30). Thymocytes continually interact with self-expressing APC 
over a period of up to 12 days (31), which ensures efficient elimination of autoreactive T 
cells prior to entering the periphery. The process of thymic selection is estimated to take 16-
19 days. As efficient and stringent as thymic selection is, some autoreactive T cells escape, 
and in the absence of sufficient peripheral tolerance mechanisms, autoimmune disease can 
result.  
Thymocytes require interactions with both cTEC and mTEC in order to survive and 
develop into T cells, however, the thymic stroma also requires thymocyte interactions in 
order to mature and develop (32-34). Mice deficient in the ability of thymocytes to progress 
through selection also exhibit reduced thymic cortical or medullary mass.  
Age Dependent Changes in Central Tolerance 
During development of both humans and mice, thymus maturation is associated with 
structural reorganization of the cortex and medulla coupled with an increase in size due to an 
expanding pool of thymic stroma, APC and thymocytes. In humans, the thymus is estimated 
to continue to develop until the teen aged years, at which time thymic involution begins (35). 
A similar phenomenon is observed in rodents, where development continues until 4 weeks of 
age, after which involution is observed (36). Ontogenic changes in thymic structure may 
impact the efficacy of positive and negative selection events.  
Other age related events may also play a role in the efficiency of thymic selection. A 
temporal role for AIRE was described, where AIRE is required to prevent autoimmunity in 
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NOD mice early in ontogeny, after 3 weeks of age AIRE was dispensable in preventing the 
development of systemic autoimmunity (37).  
Another ontogenically regulated key event that may influence the efficacy of thymic 
selection is the origin of thymocyte precursors. During embryonic development in mice, T 
cell precursors are derived from the liver up until embryonic day 13 (38, 39) followed by a 
switch to bone marrow derived precursors by embryonic day 15. Key phenotypic differences 
exist between thymocytes derived from embryonic liver versus adult bone marrow. 
Thymocytes derived during embryonic development are hyperproliferative (40-42) whereas 
adult thymocytes exhibit little proliferative ability (43). Embryonic precursors give rise to 
longer lasting thymocytes when compared to those derived from bone marrow (42, 44). In 
addition, embryonic precursors have been shown to utilize V6 as well as V11 in much 
higher frequency than their adult counterparts (45, 46). Although an investigation into 
particular specificities has not been completed, disparate usage of particular V chains based 
on precursor origin is suggestive of differences in specificity. Taken together, it is plausible 
that a functional difference exists in thymic selection early versus later in ontogeny.  
Onset of Type 1 Diabetes Primarily Occurs in Younger Individuals 
T1D has been commonly referred to as “juvenile diabetes”, implying that disease 
onset primarily occurs in young individuals. Evidence for a skewing towards early onset was 
provided in an epidemiologic study of European populations which described disease onset 
in humans primarily occurring prior to 14 years of age (47). Early development of disease is 
mirrored in the NOD mouse, where insulitis typically begins at 3 weeks of age, progressing 
to clinical onset between 15 and 25 weeks of age. Evidence of early production of 
autoreactive T cells can also be observed by the minimal impact on disease incidence in 
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NOD mice thymectomized at day 3 post birth (48, 49). Suggesting a sufficient number of 
autoreactive T cells have been produced by 3 days of age for disease to develop.  
Early disease development provides support that autoreactive T cells are produced 
early in ontogeny. However, the question remains if autoreactive T cells are continuously 
produced at the same frequency throughout life. In view of the various age-dependent 
changes in the thymus and thymocyte precursors, an intriguing hypothesis is that early in 
ontogeny, autoreactive T cells more readily escape negative selection. The implications of a 
narrow developmental window of autoreactive T cell production would provide a temporal 
target to intervene in the prevention of T1D.  
Insight into Basic T Cell Biology By Manipulating T1D Via Immunotherapy 
Identifying therapeutic targets is paramount in preventing and treating T1D. The body 
of knowledge currently available provides us with a large source of potential targets, 
however, basic knowledge in the mechanisms behind T cell production and activity is still 
lacking. One of the defining characteristics of T cells is their ability to rapidly circulate 
through the body, searching for cognate antigen and to respond as needed. However, 
regulation of T cell circulation in the absence of an inflammatory environment is still not 
fully understood. A novel approach to combating autoimmune disease would be one where 
pathogenic T cells are rendered unresponsive to inflammatory cues to block tissue pathology.   
We recently reported that nondepleting anti-CD4 (YTS177) and anti-CD8 (YTS105) 
antibodies induce long-term remission in newly diabetic NOD mice (50). Notably, distinct 
mechanisms of induction and maintenance of remission are established by coreceptor 
therapy. The non-depleting antibody immunotherapy is cleared from recipients within 45 
days post administration; however,  cell tolerance is maintained. We have demonstrated that 
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Foxp3+ Treg isolated from maintenance phase long term remission animals are able to 
suppress the adoptive transfer of diabetes. In vitro models have also demonstrated an 
increased suppressive ability of Foxp3+Treg isolated from long term (>100 days) treated vs 
untreated NOD mice. For the purpose of this thesis, we will concentrate on the effect of only 
the anti-CD4 (YTS177) immunotherapy during the induction phase of remission, which is 
characterized by T cell purging from the pancreas and PLN. While YTS177 alone is not 
capable of inducing diabetes remission, it is capable of causing CD4+ T cell migration from 
the pancreas and peripheral lymph nodes. 
T Cell Migration From Blood to Lymphoid Tissue  
T cell migration is a dynamic process where environmental cues signal T cells to 
phenotypically change to promote directed and purposeful movement. T cells are among the 
most migratory cells in the body (51), continually circulating from blood to the lymphatics 
(52), termed homing. Circulating T cells have a circular morphology with even distribution 
of chemokine receptors (CKR) and adhesion molecules. In response to chemokines or 
vascular expressed adhesion molecules, T cells begin to slow, roll, and tether to endothelial 
surfaces (53). This is primarily accomplished through the interactions of CD62L binding to 
its respective ligand glycosylation-dependent cell adhesion molecule-1 (GlyCAM-1) (or 
other sialylated ligands) (54). Firm adhesion ultimately halts circulating T cells via the 
interaction of leukocyte function-associated molecule-1 (LFA-1) or 41 with their 
respective ligands inter-cellular adhesion molecule-1 (ICAM-1) and vascular adhesion 
molecule-1 (VCAM-1) (55). T cell migration is accomplished via polarization, which is 
characterized by the formation of a leading edge (lamellipodium) and a trailing uropod (56). 
The leading edge becomes enriched with CKR which assist in providing directional cues for 
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the T cell. The leading edge also becomes enriched with polymerizing F-actin, creating 
cellular protrusions which serve to pull the cell forward, allowing for transendothelial 
migration. The uropod becomes enriched with a variety of adhesion molecules such as CD43, 
CD44, ICAM-1 and others (57). The function of the uropod is still unclear, however it has 
been suggested that it may sequester adhesion molecules not required for transendothelial 
migration (58).  
T cells enter lymphoid organs by crossing high endothelial venules (53). Following 
lymph node entry, T cells “sample” or “scan” MHC presented antigen by APC searching for 
recognition of their cognate antigen, this process is regulated by the interaction of LFA-1 on 
T cells and ICAM-1 on APC (59). When antigen recognition occurs, “sampling” turns to firm 
adhesion via the generation of the immunological synapse (IS) (60). In the absence of antigen 
recognition, T cells disengage from their initial contact and either continue to sample MHC 
presented antigen or egress from the lymphoid tissue to return to circulation. The molecular 
events leading to lymph node egress are not fully understood; however, T cells must again 
polarize and cross endothelial barriers in order to return to circulation (61).  
Intracellular Events Leading to T Cell Migration  
Migration of T cells through circulation and lymphatics is controlled by signaling 
which originates from environmental cues, such as activation, chemokine, or adhesion 
signals. The most widely studied stimulus has been that derived from the activation of the 
TCR signaling cascade. Upon TCR recognition of cognate antigen, T cells form an IS with 
APC (60, 62). The association of the T cell:APC interaction is regulated by adhesion 
molecules, primarily LFA-1 and ICAM-1, on T cells and APC, respectively (59). CD4 or 
CD8 coreceptor engagement is important in regulating the strength and duration of the TCR 
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signal. Upon binding of CD4 to conserved regions of the MHC class II molecule expressed 
by APC, the Src family tyrosine kinase, lymphocyte-specific protein tyrosine kinase (Lck), 
becomes active via phosphorylation at tyrosine 394 (63). Having adopted kinase potential, 
p394 Lck is then able to phosphorylate ZAP-70 (64) which in turn acts as a kinase in the 
phosphorylation of the guanine nucleotide exchange factor (GEF), Vav (65). GEFs have the 
ability to activate small Rho GTPases, such as Rac, by facilitating the exchange of GDP for 
GTP. A limited number of GEFs have been described in the context of T cell activation and 
migration including: Vav, Tiam1, Dock2, and Sos (66, 67). The utilization of different GEFs 
in the activation of Rac has been associated with distinct phenotypic activities (66). Rac 
activation through the activity of Dock2 or Tiam1 has been associated with lymph node 
egress (68-70). Vav1 activation of Rac has been linked to T cell activation (71), although 
evidence also exists showing Vav regulation of cytoskeletal reorganization, suggesting a role 
in polarization and migration (72, 73). A role for Sos has been more difficult to determine, as 
Sos1 knockout mice exhibit embryonic lethality (74). 
Although three isoforms of Rac have been described: Rac1, Rac2, and Rac3; only the 
first two have been described in the context of T cell activity. While Rac1 is ubiquitously 
expressed in most cell types, Rac2 is restricted to mainly T, B, and myeloid hemopoietic cells 
(75-77). Each isoform has been suggested to control different aspects of T cell function. Rac1 
is known to control lamellipodium formation, a branch actin network used to create forward 
motility (78). Rac1 is also implicated in cytoskeletal rearrangements leading to lipid raft 
formation and clustering (79). Most Rac1 functional studies have been performed either in 
cell culture or in the context of overexpression or constitutive activation, due to the fact that 
Rac1 knockout mice are not viable (80); Rac2 knockout mice have, however, been 
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established (81). T cells from Rac2 knockout animals exhibit defects in polarization and actin 
polymerization, as well defects in downstream TCR signaling (82). The common theme of 
both isoforms of Rac is control of the cytoskeleton and as such, polarization and migration. 
In short, Rac is the molecular switch, toggling T cells between a stationary and migratory 
state. 
Downstream effector molecules of Rac activation can vary, however. Control of the 
cytoskeleton is accomplished mainly through an association with the Wiskott-Aldrich 
syndrome protein (WASP) (83). WASP knockout mice exhibit a phenotype very similar to 
those of certain GEF knockouts, where T cells have a defect in activation and polarization 
(84). Activation defects can be traced back to an inability to modulate the cytoskeleton in 
response to activation cues, for instance, blocking upstream Rac activation results in a failure 
of PKC- to localize to the IS during TCR priming, and as such prevents downstream TCR 
signaling (73). 
In this dissertation, we examine two processes involved in T1D pathogensis: 1) the 
identification of a narrow age window in which autoreactive T cells are produced, which 
ultimately leads to the development of autoimmune disease, and 2) the identification of a 
novel TCR independent signaling pathway resulting in T cell migration away from the 
pancreas and pancreatic lymph nodes, which is activated following antibody mediated 
crosslinking of the CD4 molecule.  
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Chapter 2: Thymic Development Of Autoreactive T Cells In NOD Mice Is Regulated In 
An Age-Dependent Manner
1 
 
Introduction 
Events ongoing in the thymus play a critical role in shaping the repertoire of T cells 
(85, 86). Positive selection in the thymic cortex generates a pool of T cells restricted to self-
MHC molecules. On the other hand, negative selection in the medulla of the thymus ensures 
that thymocytes reactive to self-antigens are purged via induction of apoptosis or anergy (14, 
87). mTEC (88-90) and dendritic cells (DC) (27, 28, 91) drive thymocyte negative selection 
by expressing and/or presenting self-antigens, respectively. A constellation of tissue-specific 
antigens (TSA) is expressed by mTEC (88, 92) and expression of many of these TSA is 
controlled by the Aire transcription factor (88, 93, 94). The parameters that influence the 
efficiency of thymic negative selection are ill-defined, but are believed to include the avidity 
of the interaction of thymocytes with mTEC and DC, intrinsic responses of thymocytes to 
apoptosis induction, and/or levels of thymic TSA expression and presentation (24, 95-98).  
                                                 
 
1
 The citation is as follows: He, Q., Morillon, YM 2nd, Spidale, N.A., Kroger, C.J., Liu, B., Sartor, R.B., Wang, 
B., and Tisch, R. (2013) Thymic Development of Autoreactive T Cells in NOD Mice Is Regulated in an Age-
Dependent Manner. Journal of Immunology. http://www.jimmunol.org/content/191/12/5858.long  
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Inefficient thymic negative selection has been associated with various T cell-mediated 
autoimmune diseases such as T1D (13, 14, 99). T1D in humans and rodent models, such as 
the NOD mouse, is characterized by the CD4
+
 and CD8
+
 T cell-mediated destruction of the 
insulin-producing  cells residing in the pancreatic islets of Langerhans (2). In NOD mice the 
diabetogenic response involves progressive insulitis in which T cells and other immune 
effectors infiltrate the islets over time. Insulitis is first detected at 3-4 wk of age and 
relatively few  cell autoantigens and epitopes are targeted by CD4+ and CD8+ T cells (100-
103). By 12 wk of age, a late preclinical stage of T1D, the islets in NOD mice are heavily 
infiltrated, marked by effector T cells (Teff) targeting numerous  cell autoantigens and 
epitopes. Aberrant survival of islet resident Foxp3
+
Treg is then believed to promote a wave 
of robust  cell destruction and the onset of overt diabetes (17, 104). NOD mice also exhibit 
T cell autoimmunity to other tissues such as the thyroid (105, 106) and salivary gland (107), 
and low levels of colitis (108, 109) are detected suggesting general defects in mechanisms 
regulating autoimmune and inflammatory responses, respectively.  
Currently, it is not known whether thymic production of autoreactive T cells in 
general, and diabetogenic T cells specifically, is a continuous versus time-limited process. 
The appearance of prevalent clones as autoimmunity progresses over time (110, 111) may for 
instance, reflect continued thymic production of autoreactive T cell clones albeit with distinct 
specificities (112). On the other hand, studies employing TCR transgenic mice specific for 
thymus-expressed neo-self antigens suggest that the efficiency of negative selection is 
reduced in younger animals (113, 114). A “window” may therefore exist early in life during 
which the development of autoreactive clones is enhanced, and the pool of anti-self T cells 
established. The latter has important implications for understanding the events that regulate 
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thymic negative selection, in addition to establishing strategies to prevent T cell-mediated 
autoimmunity.  
We investigated the ontogeny of autoreactive T cells using a thymus transplant 
approach. Immunodeficient NOD.scid recipients were implanted with thymus grafts from 
different aged NOD donor mice, and the pathogenicity of the resulting T cell pool assessed. 
Here we demonstrate that thymic production of organ-specific autoreactive Teff is limited to 
a 10 d period after birth, indicating that the efficacy of thymic negative selection is regulated 
in a temporal manner. 
Materials and Methods 
Mice.  
NOD/LtJ, NOD.CB17-Prkdc
scid
/J (NOD.scid), and NOD.129S2(B6)-Aire
tm1.1Doi
/DoiJ 
(NOD.Aire
null
) were originally purchased from The Jackson Laboratory (Bar Harbor). 
NOD.Cg-Tg(TcrTcrBDC2.5)1Doi/DoiJ (NOD.BDC2.5) mice have been previously 
described (115). NOD.BDC2.5 mice were bred with NOD.129P2(C)-Tcra
tm1Mjo
/DoiJ 
(NOD.Cnull) mice to generate NOD.BDC2.5.Cnull mice. All mice were bred and 
maintained in specific pathogen-free facilities at the University of North Carolina at Chapel 
Hill. Mouse experiments were approved by the University of North Carolina at Chapel Hill 
Institutional Animal Care and Use Committee. 
Thymus transplantation and disease assessment. 
Thymic lobes from newborn (within 48 hr of birth) and various aged female NOD or 
NOD.Aire
null 
mice were implanted under the kidney capsule of 6 wk-old female NOD.scid 
mice.  NOD.scid recipients were monitored for diabetes by measuring blood glucose weekly; 
blood glucose levels >250 mg/dl (Abbott Diabetes Care Inc) for 2 consecutive measurements 
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were scored as diabetic. The body weight of animals was measured weekly, and the 
development of weight loss was considered as the clinical onset of colitis. 
Immunohistological analyses. 
Various tissues were fixed in 10% neutral buffered formalin (Fisher Scientific), 
paraffin embedded, and non-overlapping sections prepared and stained with hematoxylin and 
eosin (H&E) or Alcian blue. Severity of insulitis and colitis were graded as previously 
described (116, 117).  
For thymus immunostaining, thymi were frozen in O.C.T. compound (Sakura Finetek 
USA) and 7μM sections cut.  Sections were fixed and permeabilized in ice cold 
acetone/methanol for 5 min, then washed in PBS.  Thymus sections were stained with UEA-
1*biotin (Sigma Aldrich) and Troma-1 (anti-cytokeratin-8) (Developmental Studies 
Hybridoma Bank, University of Iowa) followed by Streptavidin*PE (eBiosciences) and 
AlexaFluor*488 goat anti-rat IgG (Invitrogen); each step was incubated 1 hr at room 
temperature. Montage thymus images were taken using a Zeiss Axioplan 2 microscope 10x 
objective, and analyzed with Slidebook software (Intelligent Imaging Innovations). 
T cell analyses. 
Cells isolated from the spleen, PLN, MLN and colon were stimulated with PMA 
(50ng/ml)/ionomycin (1g/ml) in complete RPMI 1640 medium at 370C for 4 to 5 hr and 
Brefeldin A was included in the culture for the last 2 hr of incubation. Cells were washed, 
stained with Abs specific for CD4 (GK1.5), CD8 (53-6.7), CD3 (2C11) and TCR (H57). 
After fixation and permeabilization using the Fixation/Permeabilization kit (eBioscience), 
cells were stained with Abs specific for intracellular IL-17 (TC11-18H10) and IFN 
(XMG1.2). Foxp3-expressing T cells were stained using an anti-mouse Foxp3 staining kit as 
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per the manufacturer’s instructions (eBioscience). T cells were stained as previously 
described (50) with in house prepared soluble IA
g7
 multimers covalently linked to BDC 
mimetic or HEL peptides or H2K
d
 tetramers complexed with IGRP  or HA  peptides (118, 
119). Data were acquired with CyAn flow cytometer (DakoCytomation) and analyzed using 
FlowJo (Tree Star Inc.) or Summit (DakoCytomation) software.  
Single cell suspensions were prepared from NOD.scid thymus recipients 6 wks post-
transplantation and 5-10x10
5
 cells/well cultured in triplicate in complete RPMI1640 and 
100g/ml cecal bacterial lysate (CBL) (120) prepared from 6 wk-old NOD mice in 96-well 
round bottom plates at 37°C for 48 hr. The supernatants were harvested, and IFN and IL-17 
measured using ELISA kits (eBiosciences) according to the manufacturer's instructions. 
For adoptive transfer experiments, splenocytes were harvested from NOD.scid 
thymus recipients 6 wk post-transplantation and CD4
+
 and CD8
+
 T cells purified by negative 
selection using mouse CD4 or CD8 T Cell Isolation Kits (Miltenyi Biotec). Female 
NOD.scid mice 6 wk of age were injected i.p. with 2x10
6
 T cells per mouse, and then 
monitored for diabetes, body weight and rectal prolapse. In some experiments T cells were 
labeled prior to transfer with CellTrace Violet (Life Technologies) according to the 
manufacturer’s instructions.  
Statistical analysis. 
Statistical tests were performed using prism 4.0 software (GraphPad). Body weight 
data were analyzed using the Two-way ANOVA. Kaplan-Meier Long-Rank Test was used to 
analyze the incidence of diabetes and colitis. Student’s t test and ANOVA were used for all 
other data.  
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Results 
Development of diabetes is restricted to a narrow postnatal thymic age.  
Thymic structural organization differs with ontogeny; the newborn thymus is 
characterized by small “islands” of medullary tissue whereas the medulla “coalesces” into a 
large, well organized structure with age (Figure 1A). To assess the ontogeny of  cell-
specific T cells, NOD.scid mice were engrafted under the kidney capsule with thymi from 
newborn and older NOD female mice, which represent different stages of T1D. Mature T 
cells were detected in the blood of thymus recipients as early as 1 wk post-implantation; by 
4-6 wk ~40% of mononuclear cells consisted of CD4
+
 T cells in recipients of newborn and 
adult thymi (Figure 1B). The reconstitution of CD8
+
 T cells, however, was delayed in adult 
versus newborn thymus recipients (Figure 1B).  
Overt diabetes was detected in all NOD.scid mice receiving newborn thymi, and islets 
exhibited significant insulitis indicating T cell-mediated  cell destruction (Figure 1C,D,  
Table I) Recipients of 7 and 10 d-old thymi remained diabetes-free; insulitis, however, was 
detected albeit at a reduced severity relative to newborn thymus recipients (Figure 1C,  Table 
I). In contrast, NOD.scid recipients of thymi from 2 wk and older NOD donors failed to 
develop both insulitis and diabetes (Figure 1C,E,  Table I). Similarly, the salivary gland and 
thyroid were infiltrated in recipients of newborn and 7 d thymi (Figure 1I,K) but not 10 d or 
older thymi (Figure 1J,L, Table I). 
Surprisingly, symptoms of colitis such as weight loss (Figure 1F, Table I), diarrhea, 
and rectal prolapse were detected in NOD.scid mice implanted with 10 d and older thymi. 
Histologic examination of the gastrointestinal tract further revealed severe colitis (Figure 1F, 
Table I) based on colonic hyperplasia, inflammation of the mucosal layer, significant 
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infiltration of the lamina propria by mononuclear cells, and the depletion of goblet cells in 
the crypts (Figure 1G,H). NOD.scid mice receiving newborn and 7 d thymi, however, 
exhibited only limited colitis and no weight loss or rectal prolapse (Figure 1F, Table I).  
Adoptive transfer experiments confirmed the organ-specific nature of pathogenic T 
cells developing in the thymus recipients. Splenocytes isolated from recipients of newborn 
and 7 d thymi readily transferred diabetes but not colitis to NOD.scid mice (Table II). In 
contrast, splenocytes from animals receiving 10 d or older thymi developed colitis but not 
diabetes (Table II). Together these findings demonstrate that thymic development of 
diabetogenic and colitogenic T cells are reciprocally regulated in an age-dependent manner. 
 cell-specific Teff are increased in the PLN of newborn thymus recipients.  
FACS analyses demonstrated that the number of CD4
+
 and CD8
+
 T cells was 
increased ~2 and ~3-fold, respectively, in the spleen, PLN, and MLN of recipients of 
newborn and 7 d old thymi versus 10 d and older thymi (Figure 2B).  
The frequency of  cell-specific CD4+ and CD8+ T cells were measured in the spleen, 
PLN and MLN of newborn, 7 and 10 d thymus recipients. IA
g7
 and H2K
d
 multimers were 
used to detect CD4
+
 and CD8
+
 T cells that recognize a BDC mimetic peptide (IA
g7
-pBDC), 
and an islet-specific glucose-6-phosphatase catalytic subunit-related protein peptide (IGRP; 
H2K
d
-IGRP), respectively.  pBDC-specific CD4
+
 T cells (121) and IGRP-specific CD8
+
 T 
cells (102) are prevalent diabetogenic clonotypes in NOD mice. The highest frequency of 
CD4
+
 and CD8
+
 T cells staining with IA
g7
-pBDC and H2K
d
-IGRP, respectively, were 
detected in the PLN of newborn thymus recipients (Figure 2D). Notably, the frequency of 
IA
g7
-pBDC
+
 CD4
+
 T cells and H2K
d
-IGRP
+
 CD8
+
 T cells progressively declined in the PLN 
of 7 d and 10 d thymus recipients (Figure 2D).  
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To examine temporal changes in antigen reactivity of colitogenic T cells, splenocytes 
prepared from thymus recipients were stimulated with CBL and IL-17 and IFN secretion 
measured. IL-17 and IFN secretion in response to CBL was substantially increased in 
cultures from animals receiving thymi from 10 d and older NOD donors (Figure 3A). CBL 
also induced IL-17 and IFN secretion in cultures prepared from newborn and 7 d thymus 
recipients albeit at significantly reduced levels (Figure 3A). CD4
+
 T cells alone from adult 
thymus recipients were sufficient to transfer diabetes (Figure 3B). The importance of T cell 
reactivity to colonic microbiota in the development of colitis was further demonstrated in 
NOD.scid recipients of thymi from 6 wk-old NOD.BDC2.5 versus NOD.BDC2.5.Cnull 
donors. Severe colitis developed in NOD.scid recipients of NOD.BDC2.5 thymus (Figure 
3C), in which T cells expressed both the BDC2.5 clonotypic and endogenous TCR. On the 
other hand, severity of colitis was markedly reduced in NOD.scid recipients when the 
specificity of NOD.BDC2.5.Cnull CD4+ T cells was restricted to the  cell autoantigen 
chromogranin A (122) (Figure 3C). Recipients of NOD.BDC2.5 (or NOD.BDC2.5.Cnull) 
thymi, however, developed diabetes (Figure 3D) indicating that colitis per se did not block  
cell autoimmunity. In sum these results demonstrate that increased thymic development of  
cell-specific T cells is restricted to a 7 d window after birth. Furthermore development of 
colitogenic T cells specific for microbiota is significantly increased at, and maintained after 
10 d of age in NOD mice.  
Thymus age-dependent development of diabetes is not due to changes in Foxp3+Treg and 
immunoregulation in the PLN of recipients. 
 
The above data indicated that thymic development of  cell-specific T cells declines 
with age resulting in reduced numbers of Teff to mediate diabetes. However, lack of  cell 
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autoimmunity in recipients of post-newborn thymi may also be due to a reciprocal increase in 
Foxp3
+
Treg residing in the PLN to block expansion of diabetogenic Teff. To distinguish 
between these two possibilities, the frequency of Foxp3
+
Treg was assessed in the spleen, 
PLN and MLN of thymus recipients. Interestingly, PLN Foxp3
+
CD25
+
CD4
+
 T cells were 
increased in newborn and 7 d versus 10 d and older thymus recipients, whereas the frequency 
of spleen and MLN resident Foxp3
+
CD25
+
CD4
+
 T cells was similar independent of thymic 
age (Figure 4A).To assess the immunoregulatory activity in the PLN, NOD.BDC2.5 CD4
+
 T 
cells were transferred into recipients of newborn and 4 wk thymi, and proliferation measured. 
No marked difference was detected in the level of NOD.BDC2.5 CD4
+
 T cell proliferation 
between the respective thymus recipients (Figure 4B).These results indicate that the block in 
 cell autoimmunity in thymus recipients is not due to an increase in the Foxp3+Treg pool or 
immunoregulation in the PLN, but attributed to reduced numbers of  cell antigen-specific T 
cells.    
The temporal development of autoreactive T cells occurs in the absence of Aire expression. 
Regulation of TSA expression by AIRE may contribute to the temporal thymic 
development of autoreactive T precursors. To test this possibility the pathology of NOD.scid 
recipients transplanted with thymi from different aged NOD mice deficient in AIRE 
expression (NOD.Aire
null
) was investigated. NOD.Aire
null
 mice lack  cell autoimmunity but 
develop multi-organ T cell-mediated inflammation (123), which includes exocrine 
pancreatitis. Tissues normally targeted in NOD.Aire
null
 mice were also infiltrated in 
NOD.scid recipients of newborn NOD.Aire
null
 thymi (Figure 5A, Table III. Relative T cell 
infiltration of organs in NOD.scid recipients of different-aged NOD.Aire
null
 thymi.). 
Strikingly, a progressive decline in T cell infiltration of the exocrine pancreas and salivary 
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glands was detected in recipients of 7 and 10 d old NOD.Aire
null
 thymi, and no infiltration of 
these tissues was observed in 4 wk-old thymus recipients (Figure 5ATable III). On the other 
hand, T cell infiltration continued to be detected in the eyes, ovaries, stomach and lungs of 
animals implanted with day 7 and older NOD.Aire
null
 thymi (Figure 5A,B). The severity of 
colitis in the recipients, however, was limited regardless of NOD.Aire
null
 thymi age (Figure 
5B). These results demonstrate that temporal regulation of thymic development of 
autoreactive T cells can occur in the absence of AIRE expression albeit for certain tissue-
specificities and not others. 
Discussion 
The dynamics of and the parameters that influence thymic output of autoreactive T 
cells are poorly understood. To address these issues a thymus transplant model system was 
employed. This approach provides a “snapshot” of the specificities of autoreactive T cells 
produced in the thymus at a given age.   
We demonstrate that thymic production of  cell-specific T cells is regulated in a 
temporal manner in NOD mice. Insulitis and diabetes developed in recipients of NOD 
newborn thymi (Figure 1C,D), which corresponded with an increased frequency of PLN-
resident pBDC-specific CD4
+
 and IGRP-specific CD8
+
 T cells (Figure 2D), 2 major 
clonotypes associated with the progression of  cell autoimmunity in NOD mice. These 
results are consistent with findings demonstrating that NOD mice develop diabetes with 
normal kinetics and incidence despite thymectomy 3 d after birth, indicating that a sufficient 
pool of diabetogenic T cells is established early in ontogeny (49). Interestingly, 
autoimmunity has been reported in immunodeficient children with congenital athymia 
receiving a human infant thymus transplant (124). Noteworthy was the progressive decline in 
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insulitis (Figure 1C) and the frequency of  cell-specific T cells in recipients of 7 and 10 d 
old NOD thymi (Figure 2D). This reduction in  cell-specific T cells was not due to a 
reciprocal increase in the pool of PLN-resident Foxp3
+
Treg or enhanced tissue-specific 
immunoregulation that would be expected to block the expansion of diabetogenic Teff 
(Figure 4). Furthermore, colitis per se had no suppressive effect on  cell autoimmunity. For 
instance, both diabetes and colitis were detected in NOD.scid mice receiving NOD.BDC2.5 
thymi (Figure 3C,D) or a mixture of splenocytes from colitogenic and diabetic donor animals 
(Appendix 1), showing that the progression of the 2 pathologies is independent and not 
mutually exclusive. Together these findings indicate that the lack of insulitis and diabetes, 
and reduced frequency of diabetogenic T cells in recipients of post-newborn thymi is the 
result of diminished thymic production of  cell-specific T cells. Importantly, thyroiditis and 
sialitis detected in newborn thymus recipients were also reduced in recipients of 7 and 10 d-
old thymi (Figure 1I-L, Table I) demonstrating that thymic production of autoreactive T cells 
in general is regulated in an age-dependent manner.  
To explain the temporal decline in autoreactive T cell production we favor a model in 
which the efficacy of thymic negative selection increases during postnatal life. Several 
mutually nonexclusive possibilities may account for this effect. Reduced expression of TSA 
due to limiting Aire expression may lead to inefficient thymic negative selection of 
autoreactive T cells in the neonatal thymus (93, 96, 98). Indeed, both the frequency of AIRE-
expressing mTEC, and mRNA expression of AIRE-dependent TSA genes such as Ins2 are 
reduced in thymi from newborn versus older NOD mice (R.T. & C.J.K; unpublished data). 
Furthermore, Guerau-de-Arellano and colleagues reported that induced expression of AIRE 
and corresponding TSA by mTEC during embryonic life and up to 21 d after birth was 
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critical to block the multi-organ autoimmunity typical of NOD.Aire
null
 mice (37). Our 
observation that recipients developed significant infiltration of the ovaries, stomach, lungs 
and eyes implanted with newborn and older NOD.Aire
null
 thymi (Figure 5, Table III) 
supports a role for AIRE in the temporal development of these tissue-specific T cells. 
Strikingly, however, exocrine pancreatitis and sialadenitis failed to develop in recipients of 
thymi from 10 d or older NOD.Aire
null
 donors (Figure 5, Table III) suggesting that AIRE-
dependent TSA expression alone does not account for the observed temporal production of 
autoreactive T cells specific for these tissues. Age-dependent changes in the stimulatory 
capacity of the thymic APC pool, due to the number, composition and/or maturation status of 
mTEC and thymic DC may contribute to the efficiency of thymic negative selection (37, 98, 
125, 126). Alternatively, the development of autoreactive T cells may reflect intrinsic 
properties of T cell progenitors residing in the thymus during ontogeny.  For example, studies 
have shown that hematopoietic stem cells that seed the thymus at various stages of ontogeny 
give rise to T cells with distinct properties and antigen specificity (127-130). The latter may 
influence the affinity and/or cross-reactivity or promiscuity of TCR specific for TSA-derived 
epitopes that are either AIRE- dependent or -independent. Finally, major changes in the 
structural organization of the medulla seen during postnatal life may impact the efficiency of 
negative selection. The rudimentary thymus of newborn animals (Figure 1A) may limit 
thymocyte interactions with medullary resident APC thereby reducing the efficiency of 
negative selection, particularly if given TSA are expressed and presented at relatively low 
levels. Efforts are ongoing to delineate what is likely to be a complex interplay between 
multiple events that regulate the temporal efficiency of thymic negative selection. 
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An interesting observation made in this study was that thymic development of 
colitogenic T cells was also temporally regulated. Negligible colitis was detected in 
recipients of newborn and 7 d NOD thymi (Figure 1F). However, severe colitis developed in 
recipients of thymi from NOD donors 10 d of age and older (Figure 1F) which was marked 
by an increased number and frequency of IL-17 and IFN producing CD4+ T cells specific 
for CBL (Figure 2B). Unlike  cell-specific T cells, which were selectively increased in the 
PLN (Figure 2D), CBL reactivity was readily detected in all tissues examined (Figure 3A), 
likely reflecting systemic trafficking of a relatively large pool of colitogenic Teff. 
Recognition of commensal microbiota antigen was necessary for colitis; recipients of thymi 
from NOD.BDC2.5.Cnull donors which express chromogranin A-specific TCR (122) failed 
to develop significant colitis (Figure 3B). In contrast, increased colitis was detected in 
animals receiving thymi from adult NOD.BDC2.5 mice, which co-express transgenic and 
endogenous TCR (Figure 3B). These findings demonstrate that in addition to autoreactive T 
cells, the development of T cells specific for exogenous (e.g. microbial) antigens is regulated 
temporally, but in a reciprocal relationship to autoimmune T cells. In this instance, 
production of T cells specific for microbial antigens is enhanced after postnatal life, 
suggesting an increase in the efficiency of thymocyte positive selection. In addition, colitis 
was detected in NOD.scid recipients of thymi from 12 wk-old C57BL/6 mice congenic for 
H2
g7
 (Appendix 2), suggesting that thymic development of colitogenic T cells is independent 
of the NOD genotype. These results further support the prevailing concept that chronic 
immune-mediated colitis is driven by microbial-responsive T cells rather than autoimmune 
responses (131). 
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Since T cell reconstitution occurred under identical conditions in NOD.scid 
recipients, lymphopenic expansion cannot explain the temporal development of autoreactive 
and colitogenic T cell repertoires. It is likely, however, that lymphopenia favored the 
differentiation of pathogenic Teff driving autoimmunity and colitis. Development of 
autoreactive T cells that is largely restricted to early ontogeny further underscores the role of 
peripheral mechanisms in maintaining life-long self-tolerance. Our findings may also in part 
explain the long-lasting and robust tolerance typically induced by administration of self-
antigen to neonates (132-134). Here, deletion early in ontogeny would be expected to 
permanently purge the corresponding autoreactive clonotype(s) from the immune system.  
In conclusion, our results demonstrate that thymic development of T cells specific for 
self and foreign antigens is tightly regulated over a short ontogenic time window. These 
findings also indicate that the pool of  cell (and other tissue)-specific T cells is to a large 
extent established early in ontogeny. A number of coordinated events within the thymus are 
likely to contribute to the temporal development of autoreactive and bacterial antigen-
responsive T cells in a reciprocal manner. Exploiting the use of the thymus transplant model 
provides a novel approach to better define these events.  
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Figure 1. Reciprocal development of diabetes and colitis in NOD.scid recipients is dependent on 
the age of NOD donor thymus. 
(A) Cytokeratin-8 (green, cortex) and UEA-1 (red, medulla) immunostaining of sections from newborn, 7 d-, 
10 d-, and 4 wk-old NOD thymi; images were taken at 100X magnification. (B) NOD.scid mice were engrafted 
with thymi from newborn (NB) or 12 wk-old (n=10) NOD female donors and the frequency of CD4+ (left 
panel) and CD8+ (right panel; *p<10-4) T cells measured in peripheral blood. (C) Diabetes (left panel; *p<10-4 
versus recipients of 7 d or older thymi; Kaplan-Meier Log Rank) and the frequency of insulitis (right panel; 
n=8; *p<10-4; Student’s t test) in thymus recipients; representative H&E staining of pancreatic sections of 
recipients of newborn (D) and 12 wk-old thymi (E). (F) Body weight (left panel; *p<10-4; 2-way ANOVA) and 
colitis scores (right panel; *p<10-4; Student’s t test) of recipients (n=8) of different aged thymi and control 
NOD.scid littermates. Representative Alcian blue stained colonic sections of recipients of newborn (G) and 12 
wk-old (H) thymi. Representative H&E staining of thyroid (I,J) and salivary (K,L) glands from newborn (I,K) 
and 12 wk-old (J,L) thymus recipients. Error bars represent SEM.   
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 Table I. T cell infiltration of organs in NOD.scid recipients of different-aged NOD thymi. 
Thymi from various-aged female NOD mice were transplanted under the kidney capsule of 6-wk-old 
NOD.scid recipients. 
 Pancreas Large Intestine Salivary Gland Thyroid 
Newborn 5/5 0/5 5/5 5/5 
7 d 5/6 0/6 6/6 6/6 
10 d 0/7 7/7 0/7 4/7 
2 wk 0/6 6/6 0/6 0/7 
4 wk 0/7 7/7 0/7 0/7 
6 wk 0/6 6/6 0/6 0/6 
12 wk 0/13 13/13 0/13 0/13 
 
 
 
 
 
 
 
Table II. Disease incidence in NOD.scid mice adoptively transferred with splenocytes from 
different-aged NOD-thymus recipients. 
 
 
  
 Diabetes Colitis 
Newborn 13/13 0/8 
7 d 5/6 0/6 
10 d 0/7 7/7 
2 wk 0/6 6/6 
4 wk 0/7 7/7 
6 wk 0/6 6/6 
12 wk 0/13 13/13 
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Figure 2. Distinct T cell 
phenotypes and specificities 
detected in recipients of 
different aged NOD donor 
thymi. 
The spleen, PLN and MLN of 
different aged NOD thymus 
recipients 8 wk-post implantation 
and control 12 wk-old intact NOD 
female mice (NOD) were assessed 
via FACS for (A) CD3+CD4+ and 
CD3+CD8+ T cell numbers (n=7; 
*p<10-2; Student’s t test), (B) the 
frequency of intracellular IFN and 
IL-17 expressing CD4+ and CD8+ T 
cells (n=7; *p<0.005; Student’s t 
test). (C) Representative FACS plots 
(left and center) and frequency of 
IL-17 producing T cells isolated 
from the large intestines of 
newborn and 12 wk-old thymus 
recipients; gated on CD3+CD4+ T 
cells (n=7; *p<0.05; Student’s t 
test). (D) The frequency of IAg7-
pBDC-binding CD4+ T cells and 
H2Kd-IGRP-binding CD8+ T cells 
with representative FACS plots from PLN isolated cells; gated on CD3+ and CD4+ or CD8+ T cells respectively 
(n=5; *p<0.05; Student’s t test). Error bars represent SEM.  
 
 
  29 
 
 
 
 
 
 
Figure 3. Colitogenic T cells respond to 
intestinal microbial antigens.  
(A) Secretion of IFN and IL-17 by isolated T cells 
stimulated with CBL, as measured by ELISA, in the 
spleen, PLN, and MLN of recipients of different aged 
thymi 8 wk post-implantation (n=7; *p<10-4; 
Student’s t test). (B) Splenic CD4+ and CD8+ T cells 
isolated from NOD.scid thymus recipients 8 wk post-
implantation, and adoptively transferred into 
NOD.scid mice, which were monitored for body 
weight loss (left panel; *p<0.05, 2-way ANOVA) and 
development of rectal prolapse (right panel; 
*p<0.05, 2-way ANOVA). (C) Representative colonic 
sections stained with Alcian blue, and colitis scores 
(*p<0.05; Student’s t test) and (D) diabetes 
incidence for recipients (n=5) of thymi from 6 wk-
old NOD.BDC2.5 and NOD.BDC2.5Cnull donors. 
Error bars represent SEM.    
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Figure 4. Development of diabetes is not due to increased Foxp3+Treg frequency or suppression. 
(A) Frequency of Foxp3+CD25+CD4+ T cells in recipients of different aged NOD thymi (n=7) 6 wk-post 
implantation or 12 wk-old intact NOD female mice (NOD). (B) In vivo proliferation of cell trace-labeled 
NOD.BDC2.5 CD4+ T cells 4 d post-transfer in the PLN of recipients of newborn and 4 wk-old NOD thymus 6 
wk post-implantation or unmanipulated NOD.scid controls. Data is reported as proliferation index (left) 
with representative FACS histograms gated on CD3+CD4+cell trace+ T cells (right) (n=5). Error bars 
represent SEM.  
 
 
Figure 5. Temporal development of autoreactive T cells is independent of AIRE in some organs. 
NOD.scid mice received thymi from different aged NOD.Airenull donors. (A) Representative H&E stained 
sections of organs; arrows highlight areas of infiltration. (B) colitis scores of different aged NOD.Airenull 
thymus recipients (n=5). Error bars represent SEM. 
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Table III. Relative T cell infiltration of organs in NOD.scid recipients of different-aged NOD.Airenull 
thymi. 
+++, Heavy/complete T cell infiltration; ++, moderate T cell infiltration; +, mild T cell infiltration. 
 
Organ NB Aire
null
 7-d Aire
null
 10-d Aire
null
 4-wk Aire
null
 
Pancreas +++ ++ + None 
Ovary +++ +++ +++ ++ 
Large intestines + + + + 
Stomach ++ ++ ++ ++ 
Lung ++ Not observed Not observed ++ 
Salivary gland ++ ++ + None 
Cecum + + + + 
Small intestines + + + + 
Eyes +++ Not observed Not observed +++ 
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Chapter 3: Altered T Cell Trafficking Following Antibody Mediated Crosslinking of 
the CD4 Coreceptor. 
 
Introduction  
T cell trafficking from lymph nodes into tissues or blood is a highly regulated 
process. Secondary lymphatics serve as a primary site for adaptive immunity. A distinct 
chemokine milieu and integrin expression profile help to maintain a non-inflammatory 
“standby” state (135, 136), such that T cells can probe for productive antigen interactions, 
and when absent, continue to traffic to additional lymph nodes. Dysregulation of appropriate 
trafficking cues and mechanisms can result in a failure to mount an efficient protective 
immune response, or in the development of a pathological response, associated for instance 
with autoimmunity. We recently reported that non-depleting antibodies specific for the CD4 
(YTS177) and CD8 (YTS105) T cell coreceptor molecules induce remission in new onset 
diabetic NOD mice (50). Remission was accompanied by a reduction of T cell cellularity in 
both the pancreatic islets, and draining PLN. This “purging” event was independent of 
apoptosis induction and was attributed to altered trafficking properties of the pancreas and 
PLN resident CD4+ and CD8+ T cells. The mechanisms involved in T cell purging from the 
PLN induced by co-receptor therapy remain unclear.  
T cells continually cycle between lymphatics and blood (52), scanning for productive 
and/or activating interactions with APCs (136, 137). Crossing between lymphatics and blood 
is an active process requiring polarization of, and interactions with, the vascular or lymphatic 
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endothelial cells by T cells (135, 138). Steady state T cells have a rounded morphology with 
evenly distributed CKRs and adhesion molecules (135, 139). Upon a productive encounter in 
lymph nodes, T cells and APCs form an immunological synapse, where T cells recognize 
cognate antigen via interactions of the TCR and the peptide-MHC complex (62, 137). 
Additional costimulatory signals, and engagement of the CD4 or CD8 coreceptors, are 
required for full T cell activation (140). Phosphorylation of LCK at tyrosine 394 (63) located 
at the intracellular region of CD4 or CD8 is an early event contributing to downstream TCR 
signaling. Once activated the cell membrane is polarized and T cells egress from lymphatics 
(138). In the absence of a productive APC:T cell interaction, T cells exit the lymph nodes and 
enter circulation in response to elevated blood levels of S1P (141), followed by re-entry into 
lymphatics.  
Like other migrating cells, T cell polarization is necessary to cross endothelial 
barriers, characterized by an actin cytoskeleton rearrangement to form a leading edge in the 
direction of migration with a retracting tail at the rear of the cell (61).  Small Rho GTPases 
are regulators of the cytoskeleton and function by cycling though an active GTP bound and 
an inactive GDP bound state (142). Rac1 regulates migration by inducing a branch actin 
network termed the lamellipodia, at the leading edge (78). T cells also undergo a specific Rac 
dependent polarization resulting in a more oblong morphology with localization of CKRs and 
adhesion molecules to different poles of the cell (66). The leading edge pole becomes a 
clustering of specific CKRs, including: CCR2, CCR5, and CXCR4 (56, 143). Also found in 
the leading edge are adhesion molecules such as LFA-1 (144, 145) which serve to slow 
circulating T cells and facilitate transendothelial migration from blood to lymphatics and vice 
versa. Polymerizing F-actin is detected at highest concentrations in the leading edge of a 
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polarized T cell, which allows extension of the leading edge, ultimately pulling the T cell 
forward or allowing for T cell scanning of APC (61). The trailing pole of a T cell is 
comprised of the “uropod”, where adhesion molecules such as ICAM-1, CD43, and CD44 
localize (144, 146).  
The T cell specific pleomorphic effects of Rac activation include: lymphoid egress or 
entrance, circulation in blood and lymphatics, or entry into target tissues (61, 147, 148). The 
different outcomes of Rac activation are contextual, but can at least partially be attributed to 
the activating GEF. For instance, Rac activation as a result of the GEF Dock2, has been 
reported to promote T cell homing to lymph nodes (149), whereas Tiam1 mediated Rac 
activation is implicated more specifically in T cell adhesion and transendothelial migration 
(70). While over 70 GEFs have been identified (150), those identified in the context of T cell 
activity belong to the Sos, Vav, Tiam, and Dock families (66, 68-70, 72, 73).  
Activation of Rac resulting in altered T cell migration has been characterized as 
downstream of T cell activation (82, 151). The signaling upstream and downstream of Rac 
activation in the absence of TCR stimulation is not well understood. We provide the first 
evidence that CD4 coreceptor crosslinking results in downstream effects independent of the 
TCR signaling cascade, leading to a T cell migratory phenotype through activation of Rac. 
The identification of this novel mechanism of T cell migration not only further clarifies the 
mechanisms of T cell trafficking in the absence of activation but also provides an additional 
target for modulating T cell activity during a pathological response.   
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Materials and Methods  
Preparation of recombinant proteins 
pGEX GST-PBD and pGEX GST-RhoAG17A fusion proteins were prepared from 
lysates from Bl21 Escherichia coli cells induced with 100 µM IPTG for 16 hours at RT. For 
GST-PBD, bacterial cells were lysed in 20 mM Tris pH 7.8, 1% Triton X-100, 10 mM MgCl2 
1 mM DTT, 1mM PMSF, and 10 µg/ml aprotinin and leupeptin. For GST-RhoAG17A 
bacterial cells were lysed in 20 mM HEPES pH 7.8, 150 mM NaCl, 10 mM MgCl2, 1mM 
PMSF, and 10 µg/ml aprotinin and leupeptin. The recombinant proteins were isolated from 
the bacterial lysates by incubating with glutathione-Sepharose 4B beads (GE Healthcare) at 
4
o
C for 4 hours. The beads were sedimented and washed 3 times in 20 mM HEPES, pH 7.5; 
150 mM NaCl, 1 mM DTT. 
GST-PBD and GST-RhoAG17A Pull-down Assay 
Rac activation assays were performed as described (152). T cells were lysed in 300 
µL of 10 mM MgCl2, 500 mM NaCl, 50 mM Tris, pH 7.8, 1% Triton X-100, 0.1% SDS, 
0.5% deoxycholate, 1mM PMSF, and 10 µg/ml aprotinin and leupeptin, cleared at 14,000g at 
4
o
C for 3 minutes and incubated with at least 20 µg of GST-PBD for 20 minutes at 4
o
C. 
Beads were then washed 3 times in 50 mM Tris, pH 7.4, 10 mM MgCl2, 150 mM NaCl, 1% 
Triton X-100, 1mM PMSF, and 10 µg/ml aprotinin and leupeptin. Active GEFs were assayed 
by binding to GST-RhoAG17A as described (153). In short it was performed as the RhoA 
activation assays with the following changes. T cells were lysed in 150 mM NaCl, 20 mM 
HEPES, pH 7.6, 10 mM MgCl2, 1% Triton X-100 1mM PMSF, and 10 µg/ml aprotinin and 
leupeptin, and incubated with GST-RhoAG17A beads for 60 minutes at 4
o
C and washed in 
the same lysis buffer. Samples were then analyzed by western blotting. 
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Western Blotting 
Samples were run on SDS-PAGE gels and transferred to polyvinylidene fluoride 
membranes (Millipore). Membranes were blocked and incubated with the specified primary 
antibodies followed by species-specific secondary antibodies conjugated with horseradish 
peroxidase. Blots were developed with a chemiluminescent HRP substrate, and visualized on 
x-ray film or ChemiDoc™ MP System (BioRad) and corresponding software. For 
quantification, blots were scanned and the intensity values determined using Image J 
software (NIH) and protein levels were normalized to control protein levels. All 
quantification graphs include ≥3 independent experiments. Error bars represent SEM. 
Immunoprecipitation  
Cells were lysed in preheated gel sample buffer containing 200 mM Tris pH 6.8, 20% 
glycerol, 4% SDS and 5% 2-ME, and boiled for 5 minutes and sheared with needle. Samples 
were then diluted with 20 volumes of 20 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100 
and 1% DOC, 10 µg/ml othrovanidate 1mM PMSF, and 10 µg/ml aprotinin and leupeptin, 2 
μg of PY-20 mAb anti-phospho-tyrosine antibody for 2 hours at 4oC. Protein G-Sepharose 
was then added and samples were rotated for 2 hours at 4
o
C. Beads were then washed in 
dilution buffer and analyzed by western blotting. All quantification graphs include ≥3 
independent experiments. Error bars represent SEM. 
Transendothelial migration assay 
Cell migration assays were performed in transwell plates (Corning) of 6.5-mm 
diameter with 3 or 5-μm pore filters. The upper transwell plate was either uncoated, coated 
with 10 µg/ml collagen IV or a primary mouse endothelial cell monolayer. Cells were added 
to the upper chamber and allowed to migrate into the lower chamber containing either 10 µM 
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S1P (Sigma) or 100 µM CXCL12 (Sigma) at 37°C and 5% CO2. An input control was taken. 
Cells in the lower chamber for each condition were collected and counted by flow 
cytometery. 
Mice 
NOD/LtJ mice were bred and maintained in specific pathogen-free facilities at the 
University of North Carolina at Chapel Hill (UNC-CH). All animal experiments were 
approved by the UNC-CH Institutional Animal Care and Use Committee. 
Antibody preparation and treatment 
The YTS177.9 hybridoma was a gift from Dr. Waldmann (Oxford, U.K.). Antibody 
was purified via ammonium sulfate precipitation from culture supernatants.  
12 week old prediabetic female NOD mice were given intraperitoneal injection (IP) with 600 
g YTS177 or the 2A3 rat IgG2a isotype control (BioXCell). 
Treatment with inhibitors 
Ly294002 (LC Laboratories): Mice were injected IP with 75mg/kg 6 hours prior to 
YTS177 or isotype treatment. An additional dose of Ly294002 was given daily until mice 
were euthanized. NSC237666 (Santa Cruz Biotechnology): Mice were injected IP with 
3mg/kg 2 hours prior to YTS177 or isotype treatment. An additional dose of NSC237666  
was given every 12 hours until mice were euthanized.  
Primary cell isolation 
Spleen and PLN suspensions were made by mechanical dissociation using frosted 
glass slides. Single cell suspensions were made by filtering suspensions through a 40 M 
nylon cell strainer (Corning). Isolation of murine peripheral blood lymphocytes was 
performed by removing 25 l blood from the tail vein, followed by isolation using 
  38 
Lympholyte M (Cedarlane). Primary mouse pulmonary endothelial cells (EC) were isolated 
from 1 week old NOD mice as described in Sobczak et al. (154) and grown in EGM-2 Bullet 
Kit (Lonza). 
Flow cytometry 
Cells were stained with anti-CD3 (145-2C11), anti-CD62L (MEL-14), anti-CD4 
(RM-4-5), anti-LFA-1 (M17/4). When appropriate, cells were fixed with 1.5% 
paraformaldehyde diluted in FACS buffer. Flow cytometry data was acquired at the UNC-
Flow Cytometry Facility using the Cyan (DakoCytomation) cytometer and analyzed with 
Summit (DakoCytomation).  
Microscopy 
Tissues were homogenized as previously described directly in 1.5% 
paraformaldehyde diluted in 2% FBS containing PBS. Cells were stained with anti-CD3 
(145-2C11), anti-LFA-1 (M17/4), Phalloidin Alexa 488 (Life Technologies). Confocal 
microscopy data was acquired at the UNC-Microscopy Services Laboratory using the 
Olympus FV500 Confocal Laser Scanning microscope. Image analysis was completed using 
Image J software (NIH). 
Statistics 
Data represent mean + SEM. Statistical comparisons of differences between sample 
means used the two-tailed Student t test and was calculated using Prism (Version 6.0; 
GraphPad).  
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Results  
Antibody mediated CD4 binding results in T cell egress from the pancreatic lymph nodes.  
We have previously reported that treating new onset diabetic NOD mice with non-
depleting anti-CD4 (YTS177) and anti-CD8 (YTS105) antibodies results in diabetes 
remission (50). Reversal of diabetes is mediated in part by purging of CD4+ and CD8+ T 
cells from the pancreas and PLN. To define the short-term effects of coreceptor crosslinking, 
12 week old pre-diabetic NOD mice were administered 600 g of either YTS177 or 2A3 (an 
isotype control), and 1, 3, or 6 days later, T cells in the spleen and PLN analyzed by flow 
cytometry (Figure 6A). Following YTS177 treatment, CD4+ T cells migrated from the PLN 
between days 1 and 3 post-treatment, reaching maximum egress by day 6 (Figure 6B). No 
reduction was observed in CD4+ T cell numbers in the spleen within 6 days post treatment. 
The YTS177-mediated decrease in PLN was concomitant with a temporal increase in CD4+ 
T cells in blood (Figure 6C).  
Migration of T cells from lymph nodes into blood is controlled by S1P levels in 
circulation interacting with the S1P receptor (S1Pr) on T cells (141). To determine if 
YTS177-bound CD4+ T cells have increased reactivity to S1P, an in vitro transwell approach 
was utilized. Chemotaxis in response to S1P across a 5 m transwell was increased in a dose 
dependent manner up to 3-fold by CD4+ T cells isolated from the PLN of YTS177 compared 
to 2A3-treated NOD mice (Figure 7A,B). To establish a more stringent barrier for T cells to 
migrate through, collagen coated transwells were employed. Under these conditions, an ~2-
fold increase in S1P-mediated chemotaxis was observed for CD4+ T cells prepared from 
YTS177 versus 2A3 treated PLN (Figure 7C). To further increase stringency and establish a 
more physiologically relevant set of conditions, a monolayer of endothelial cells was cultured 
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on the surface of the transwells. Endothelial cells provide receptor-ligand interactions, as 
well as junctions for T cells to traffic through. Albeit reduced, under these more stringent 
conditions, the frequency of YTS177 treated CD4+ T cells migrating across the endothelial 
coated transwells was increased ~3-fold relative to CD4+ T cells from 2A3-treated animals 
(Figure 7D). Increased migration of YTS177 treated T cells towards S1P was not due to 
upregulated S1Pr expression, as no difference in receptor surface expression was observed 
following YTS177 treatment (Figure 7F). Increased chemotaxis by YTS177-treated T cells 
was also observed in response to CXCL12 (SDF-1) (Figure 7E). Notably, under all of the 
experimental conditions tested, CD8+ T cell chemotaxis was unaltered demonstrating the 
specificity of the effects of YTS177 binding to CD4 (Figure 7). Taken together, these results 
suggest that CD4+ T cells exhibit an enhanced migratory phenotype after YTS177 treatment, 
which is not specific to the chemotactic cues of just one chemokine. 
Increased migration is a function of T cell polarization. 
T cell polarization results in clustering of CKRs to the leading edge, which in the 
absence of CKR upregulation allows for greater sensitivity to chemotactic cues. T cell 
polarization was examined via confocal microscopy. Consistent with characteristic 
polarization, increased localization of F-actin and LFA-1 to the leading edge, as well as an 
altered, oblong morphology was observed 6 hours post YTS177 treatment (Figure 8A). Forty 
eight hours post YTS177 treatment, immediately prior to lymph node egress, T cell 
polarization was increased ~2-fold compared to steady state T cell polarization (Figure 
8B,C). The finding of a phenotypic promigatory change in T cells following CD4 coreceptor 
engagement is consistent with the observed increase in transwell migration (Figure 7A-E) 
and provides a mechanism for lymph node egress in the absence of CKR upregulation.  
  41 
Retention and entry of T cells in lymph nodes is adhesion molecule dependent, 
specifically the expression of the integrin LFA-1 and the selectin CD62L. Six hours post 
YTS177 treatment, a reduction in LFA-1 expression was detected (Figure 8D) suggesting a 
reduction in lymph node retention (155). A reduction in CD62L expression was also seen by 
6 hours post YTS177 treatment (Figure 8E), suggesting reduced potential for entry into 
lymph nodes. Together these data suggest a phenotypic change in T cells resulting in a 
polarized and migratory phenotype directed out from lymphatics and into circulation.  
Signaling downstream of CD4 engagement results in a pro-migratory phenotype.  
T cell polarization is controlled by activation of the small RhoGTPase Rac1 and 
Rac2. To investigate the mechanism of T cell polarization and migration as a result of CD4 
engagement, activation of Rac1 and Rac2 in T cells isolated from the PLN of YTS177 or 
2A3 treated NOD mice was assessed. A temporal increase, reaching a maximum of ~3 and 
~8-fold for Rac1 and Rac2 activation, respectively, was detected by 6 hours post treatment 
with YTS177 versus 2A3 (Figure 9A).  
T cell egress from lymph nodes and migration into circulation requires T cell 
polarization; circulating cells do not require polarization, as such, should not exhibit Rac 
activation. To determine if the effect is specific to lymph nodes, we compared Rac activation 
of lymph node and spleen derived cells from YTS177 and 2A3 treated mice. No significant 
difference in the activation of either Rac1 or Rac2 was observed in the spleen of YTS177 
versus 2A3 treated animals (Figure 9) consistent with the lack of T cell purging in the spleen 
(Figure 6B).  
Classically, Rac activation has been described downstream of TCR signaling (82, 
151, 156). The Src family tyrosine kinase LCK is the immediate downstream signaling 
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molecule of the CD4 coreceptor. LCK can be found in an active state, characterized by its 
phosphorylation at tyrosine 394, or an inactive state exhibiting phosphorylation at tyrosine 
505 (157). Six hours post YTS177 treatment, active LCK was reduced with a concomitant 
increase in the inactive form (Figure 10A). LCK has been shown to initiate the TCR 
signaling cascade; therefore reduced kinase activity by LCK would result in a reduction of 
TCR signaling. Reduced LCK activity suggests the classical model of Rac activation through 
TCR signaling would not apply, as such, an alternate pathway must be responsible.  
To determine the upstream GEF responsible for Rac activation after YTS177 
treatment, a Rac.G15A pulldown was performed, which serves to isolate all activated Rac 
GEFs. No increase following YTS177 treatment was detected in the activity of Vav1, Vav2, 
or Dock2, which are GEFs normally associated with T cell Rac activation (Figure 10B). To 
identify the Rac GEF mediating YTS177-induced Rac activation, the Rac GEF inhibitor 
NSC237666 was utilized. This inhibitor blocks activation of Rac1 by a specific family of 
GEFs that includes Tiam1 and Trio. NSC237666 had no marked effect on YTS177-induced 
purging of CD4+ T cells in the PLN (Figure 10C). These data indicate that the class of GEFs 
inhibited by NSC237666, including Tiam1 and Trio, play no role in Rac activation and the 
downstream migratory phenotype we observe after YTS177 treatment.  
Phosphoinositide 3-kinase (PI3K) signaling in T cells is associated with a number of 
events including T cell migration and activation of T cell-associated GEFs such as Vav, Sos, 
Dock, and Tiam. Accordingly, the effect of the PI3K inhibitor Ly294002 on YTS177-
mediated purging of the PLN was examined. At day 3 post treatment, PI3K inhibition 
utilizing a dose and regimen shown to effect in vivo leukocyte migration (158) had no effect 
on YTS177-mediated PLN egress (Figure 10D). Although this was again a negative result, it 
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provided us with evidence that the observed migratory phenotype following YTS177 
treatment was independent of PI3K activation and that the involved GEF was not reliant on 
PI3K activity.  
Discussion 
We provide evidence that CD4 crosslinking can have marked effects on the 
trafficking properties of T cells by: 1) promoting Rac1/2 activation and membrane 
polarization, 2) downregulating surface adhesion molecules, and 3) enhancing reactivity to 
chemokines such as S1P and CXCL12.  
Sequestration of adhesion molecules and CKR to the poles of T cells is characteristic 
of T cell polarization and is typically associated with enhanced cellular migration. Although 
receptor clustering was not investigated, we observed clustering of adhesion molecules and 
cytoskeletal changes consistent with T cell polarization (Figure 8A,B). Literature describes a 
role for both Rac1 and Rac2 in the polarization and migration of T cells in response to 
activation cues (61, 147). Our demonstration of increased Rac activation within hours after 
antibody mediated CD4 crosslinking would suggest an increased migratory capacity. The 
mechanisms of Rac mediated migration are known to be via cytoskeletal changes and T cell 
polarization (61). Consistent with this, we observed increased Rac activation and polarization 
within 6 hours post YTS177 treatment, which in the case of polarization becomes statistically 
different from isotype control treated T cells within 48 hours post treatment. T cell 
polarization results in increased sensitivity and efficiency in responding to chemokines. 
Normally, activation of T cells, and as a result Rac activation, promotes an increase in the 
kinetics of lymphoid egress. We find it likely that the delayed kinetics of T cell egress in our 
model are most likely due to a lack of sufficient chemotactic cues at the time of treatment, 
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where in the case of T cell activation, an inflammatory environment would be present to 
immediately direct T cells to target tissue. In the case of antibody mediated crosslinking of 
CD4, we hypothesize that only by 2 days post treatment has a sufficient shift in the 
chemokine gradient occurred towards circulation to warrant lymph node egress. In short, T 
cells are primed to migrate early after treatment, but in the absence of a sufficient directional 
cue, remain in the lymphatics.  
In addition to polarization, Rac is associated with expression of the integrin LFA-1, 
which controls T cell:DC and T cell:endothelial interactions via association with its ligand 
ICAM-1 (55). T cells from LFA-1 knockout mice exhibit accelerated egress from lymph 
nodes, and as such have reduced numbers in peripheral lymph nodes (155). LFA-1 blockade 
results in populations of T cells exiting the lymph nodes and entering blood (159). Following 
YTS177 treatment, we observed a systemic CD4 specific downregulation of LFA-1. 
Although the mechanism of LFA-1 blockade mediated egress is unclear, the importance of 
further investigation is highlighted by the fact that this approach is currently being 
investigated for clinical use in the context of islet transplantation tolerance (160).  While it 
has been described that LFA-1 plays a central role in lymph node entry and egress (155), 
mechanisms remain ill defined. Our model provides insight into the potential upstream and 
downstream mediators of LFA-1 activity.  
The pro-migratory phenotype observed after YTS177 treatment may serve to 
accelerate lymph node egress, however trafficking out of lymph nodes into circulation is a 
normal phenomenon. Under static conditions, following egress, T cells circulate followed by 
re-entry into the lymphatics. Extravasation from circulation and into lymphatics is initiated 
by tethering then rolling along the vascular endothelium, which is mediated by the adhesion 
  45 
molecules LFA-1 and CD62L interacting with their respective ligands ICAM-1 and 
GlyCAM-1 (161), among others. The importance of CD62L in the entry of T cells into 
lymphatics is highlighted by the fact that CD62L deficient mice exhibit deficiencies in 
homing to lymph nodes (162). The observed systemic decrease in CD62L expression 
following YTS177 treatment may play a role in preventing T cell extravasation and re-entry 
into lymph nodes. Together, these data would support a model where T cells exit the 
lymphatics and are then unable to return and therefore remain in circulation. 
The current model of Rac-mediated T cell polarization and migration is dependent on 
TCR activation. The inactivation of LCK (Figure 10A) suggested an alternative signaling 
pathway induced by CD4 upon YTS177 binding. A similar result was reported following 
HIV gp120 binding to CD4 (163), where increased Rac activation was observed; other 
studies have also shown that gp120 binding inactivates the TCR signaling cascade (164). 
While we cannot conclude that the downstream signaling resulting from antibody and gp120 
binding are identical, it provides support of an inactivating TCR signal resulting in Rac 
activation. Additionally, we have demonstrated Rac activation independent of the GEFs 
Vav1, Vav2, Trio, Dock2, and Tiam1, those normally implicated in T cell activation 
dependent migration (66, 68-70, 72, 73). Taken together, these data provide evidence of an 
alternate pathway to T cell polarization and migration.  
In short, T cell Rac activation results in downstream phenotypic changes normally 
associated with polarization and migration out of lymphatics. The classical pathway of T cell 
polarization has been one centered around TCR activation signals, our data suggests a model 
where migration occurs in the absence of TCR signaling. We provide evidence that LCK, the 
molecule associated with CD4 and the initiation of TCR signaling, exhibits an inactive state 
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within 6 hours after CD4 crosslinking. Although we were unable to identify the GEFs 
activating Rac, we are able to rule out those normally associated with Rac activation in the 
context of positive/activating TCR signaling. Taken together, our data supports a model 
where antibody mediated CD4 engagement causes downstream signaling independent of the 
TCR, resulting in Rac activation. Rac acts as a molecular switch, ultimately turning on a 
migratory program in T cells, resulting in their egress from lymph nodes and into circulation, 
and that a loss of adhesion molecules results in their inability to re-enter lymphatics (Figure 
12).   
T cells searching for activation through cognate antigen recognition continually 
migrate between circulation and lymph nodes. Activation of CD4+ T cells typically occurs in 
the lymph nodes and results in T cell polarization. Likewise, a lack of TCR activation also 
results in T cell polarization and mobilization. The ultimate action of T cells is context 
dependent, in the case of an immune response, T cells enter target tissues, in the absence of 
an immune response, T cells enter circulation. The primary difference between the two 
scenarios, outside of T cell activation, is the surrounding cytokine environment and 
chemokine gradient. Regardless of inflammatory state, T cells are primed for directed 
movement. The ability to control T cell polarization and migration provides a unique 
approach to control a pathological inflammatory response associated with autoimmunity for 
instance. Indeed, co-treatment with non-depleting anti-CD4 and -CD8 antibody is highly 
effective at suppressing ongoing  cell autoimmunity and reversing diabetes in NOD mice. 
A role for Rac1 and Rac2 mediating the T cell polarization and egress induced by 
CD4 crosslinking is likely, however, experiments are still needed to directly confirm this 
role. Future studies will investigate the in vitro migratory potential of YTS177 treated T cells 
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across transwells following the knockdown of Rac via lentiviral expression of shRNA. We 
will also further investigate the TCR independent nature of polarization and migration by 
utilizing the upstream TCR signaling inhibitor Desatineb, which inhibits LCK activation, as 
well as the downstream TCR signaling inhibitor FK506, which inhibits calcineurin. We are 
confident that future data will continue to support our model of alternative pathway 
activation of Rac resulting in T cell polarization and lymph node egress.   
  
Figure 6. T cells migrate from lymph nodes and enter circulation following administration of 
YTS177. 
(A) Representative flow cytometric plots of CD3+ T cells isolated from the PLN of mice 6 days post treatment 
of 600 g of isotype control 2A3 (left) or YTS177 (right). (B) The number of CD4+ T cells isolated from the 
spleen and PLN of 2A3 or YTS177 treated mice at day 1, 3, or 6 post treatment (n=3; p<0.05, Student t test) 
(C) The number of CD3+ T cells per l of blood in mice treated with either 2A3 or YTS177 at day 0, 3, or 6 
post treatment (n=10; p<0.05, Student t test). 
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Figure 7. CD4+ T cells exhibit increased sensitivity to chemokines after YTS177 treatment. 
(A) Percent chemotaxis of input CD4+ T cells in response to varying concentrations of S1P (n=3; p<0.05; 
Student t test). Percentage of input CD4+ or CD8+ T cells migrating across a 5 M (B) unmanipulated (n=6), 
(C) collagen (n=4), or (D) endothelial cell (n=6) coated transwell in response to 10 M S1P (p<0.05, Student 
t test). (E) Percentage of input CD4+ T cells migrating across a transwell in response to 100 M CXCL12 
(n=6; p<0.01, Student t test). (F) Flow cytometric analysis of S1Pr stained PLN derived CD4+ T cells 48 hours 
post YTS177 treatment (n=3). 
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Figure 8. PLN derived T cells rapidly adopt a polarized phenotype following YTS177 treatment. 
 (A) Representative images of YTS177 treated/polarized and isotype control 2A3 treated/unpolarized T cells 
exhibiting localization of F-actin (green) and LFA-1 (red) (400X magnification with digitial zoom). (B) 
Representative images used for quantification of polarization stained for F-actin (green) and CD3 (blue). (C) 
Quantification of polarization of PLN-derived T cells harvested 48 hours post-YTS177 or 2A3 treatment, at 
least 500 T cells were scored from each mouse (n=5; p<0.05, Student t test). LFA-1 (D) and CD62L (E) 
expression was assessed for CD4+ T cells isolated from YTS177 or 2A3 treated animals 6 hours post 
treatment (n=6; p<0.005, Student t test). 
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Figure 9. Increased Rac1 and Rac2 activity in PLN T cells after YTS177 treatment. 
(A) Active Rac1 was examined in T cells isolated from NOD mice at 1 (n=3), 3 (n=3), and 6 hours (n=7) post-
2A3 or -YTS177 treatment and measured via immunoblot (left); relative Rac activity is presented as a fold 
increase in densitometric readings (right) comparing YTS177 vs 2A3 treated (p<0.05, Student t test). (B) 
Similarly, active Rac1 and Rac2 was examined for T cells isolated from the spleen (n=5) and PLN (n=7) of 
2A3 or YTS177 treated NOD mice 6 hours post-treatment; graphs report a densitometric fold increase in 
YTS177 versus 2A3 treated (P<0.05, Student t test). 
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Figure 10. Altered activity upstream of Rac activation in T cells following YTS177 treatment. 
(A) Representative immunoblots (left) for p505.LCK (top) and p394.LCK (bottom) with corresponding 
densitometric measurements (right) (n=3; p<0.05, Student t test). (B) Representative GEF immunoblots 
following Rac.G15A pulldown of cells isolated from the PLN of YTS177 or isotype treated mice 6 hours post 
treatment. (C) CD4+ T cell numbers in the spleen and PLN of NOD mice 5 days post-YTS177 or 2A3 
treatment + Rac.GEF inhibitor NSC237666 injected every 12 hours (n=5; p<0.05, Student t test). (D) CD4+ T 
cell numbers in the spleen and PLN of NOD mice 3 days post-YTS177 or 2A3 treatment + PI3K inhibitor 
Ly294002 or PBS injected daily (n=3; p<0.05, Student t test). 
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Chapter 4: Discussion 
 
Discussion  
 
Two major themes have been discussed in this dissertation: 1) the definition of a 
narrow age window during which thymic development of autoreactive T cells is increased, 
and 2) the description of a novel signaling cascade transduced by antibody binding to CD4 
that in turn establishes a pro-migratory phenotype in T cells.  
The key events driving thymic development of autoreactive T cells are ill-defined. 
Our thymus transplant approach described in Chapter 2 provides a “snapshot” of thymic 
production of autoreactive T cells as a function of age. Notably, development of autoreactive 
T cells was largely restricted to a period within 10 days post-birth. We argue that this is the 
consequence of reduced efficiency in thymic negative selection, which may be due to a 
number of mutually nonexclusive scenarios involving temporal changes in: thymic stroma 
maturation, and the source of thymocyte precursors and related intrinsic properties (Figure 
11).  Since, thymic epithelial cells (TEC) require interactions with thymocytes to fully 
mature, it is possible that due to limited interactions early in ontogeny, TEC mostly exhibit 
an immature phenotype which would favor inefficient T cell selection. As mice age and the 
thymus undergoes marked structural reorganization of the cortex and medulla, interactions 
between thymocytes and TEC are more readily facilitated to enhance maturation and in turn 
the function of TECs.  
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The source of T cell precursors may also play a role in the thymic development of 
autoreactive T cells. The liver is the primary source of thymocyte precursors up until day 13 
of embryonic development, after which, precursors are derived from bone marrow. 
Consequently, early after birth the majority of thymocytes will have been derived from 
“liver” thymocyte precursors. Preliminary experiments comparing embryonic liver versus 
adult bone marrow in the development of  cell autoimmunity are consistent with this model. 
Various aged NOD.scid thymi were transplanted under the kidney capsule of NOD.scid 
recipients, which then received embryonic liver- or adult bone marrow-derived stem cells. 
Development of insulitis was only observed in recipients of both newborn thymi and 
embryonic liver-derived thymocyte precursors. These data suggest that embryonic precursors 
promote the development of a pool of thymocytes sufficient to drive autoimmunity.  The 
latter may reflect for instance reduced sensitivity of embryonic liver-derived thymocytes to 
apoptosis induction. Notably, induction of apoptosis has been shown by some to be limited in 
NOD thymocytes. Interestingly, various studies have reported differential V chain usage 
between embryonic and adult thymocyte precursors (45, 46) suggesting development of T 
cells with distinct specificities. With this in mind, it is possible that the TCR repertoire of 
thymocytes derived from embryonic liver may exhibit a bias towards self-reactivity, which 
combined with inefficient thymic selection readily leads to the development of autoreactive T 
cells early after birth. The TCR repertoire is also likely to be further influenced by the 
peptide binding properties of MHC class I and II molecules.  Susceptibility to type 1 diabetes 
in NOD mice and humans is strongly associated with specific alleles of MHC class II 
molecules. In NOD mice for instance, IA
g7
 (165) has been reported to exhibit poor peptide 
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binding properties, which is expected to limit the efficacy of negative (166) and positive 
(167) selection. 
We have provided data supporting a model where a defect in central tolerance early in 
ontogeny results in the escape of autoreactive T cells, and in NOD mice, the development of 
autoimmunity. We have also provided evidence that the development of T cell mediated 
disease in some autoimmune prone organs is independent of the transcription factor AIRE. 
Although important observations, further elucidation of the mechanisms defining the 
temporal production of autoimmune T cells would prove beneficial from both a basic 
immunology standpoint, as well as providing additional targets with which to combat 
autoimmune disease. We have provided a number of hypotheses which could result in the 
age dependent development of autoimmunity, including incomplete thymic development 
early in ontogeny, as well as the source of thymocyte precursors changing during 
development. 
Investigating the role of thymocyte precursors in the temporal development of 
autoimmunity could be accomplished in vitro utilizing a reaggregate thymic organ culture 
approach, where thymocyte depleted thymic stroma from different aged NOD mice are 
cultured with double negative thymocytes from donors of various ages, followed by IAg7-
peptide multimer staining and FACS analysis for diabetogenic specificities. Development of 
autoreactive T cells in only those cultures seeded with embryonic precursor would suggest a 
role for precursor origin in the temporal production of autoreactive T cells. In contrast, 
increased production of autoreactive T cells in cultures seeded with only newborn thymic 
stroma, regardless of precursor source, would suggest a role for thymic age in the observed 
temporal development of autoreactive T cells. An in vivo approach to determining precursor 
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involvement would be similar to those described earlier in this chapter, where newborn 
NOD.scid mice would be given T cell precursors isolated from various aged NOD mice. 
Development of autoimmunity in only those recipients of embryonic precursors would again 
suggest precursor involvement in the age dependent development of autoimmunity.   
In order for the development of type 1 diabetes, T cells must first traffic to the PLN, 
remain in the lymph node and interact with APCs presenting self-peptide-MHC complexes to 
become activated, followed by migration into the pancreas to mediate cell destruction. 
Preventing any step of T cell migration, retention, or activation has been shown by our 
studies and those of others to have marked effects on the disease process.  
 Our studies described in Chapter 3 define a unique pathway that promotes a T cell 
pro-migratory program via engagement of the CD4 coreceptor (Figure 12). This effect is 
independent of TCR signaling since purging of the PLN and pancreas is seen for all T cells, 
including naïve T cells. The observed transient T cell polarization, reduction in retention 
cues, and increased migration in response to Rac activation, results in lymph node egress; 
downregulation of adhesion molecules is then believed to prevent T cells from returning to 
the lymphatics. 
We were unable to identify the upstream GEF resulting in Rac activation, or the 
direct downstream effector of CD4. Known activating GEFs were ruled out by either 
immunoblotting or utilizing GEF inhibitors. The ultimate cellular phenotype arising from 
small RhoGTPase activation is reliant on the activating GEF as well as its localization. There 
are many described Rac GEFs (150), however, in the context of T cells, there are few. The 
dependence of Rac activation on migration, in addition to the highly motile nature of T cells, 
make it surprising that additional GEFs have not been described. A mass spectrometry 
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approach can be used to identify either a novel GEF, or a GEF previously not described in 
the context of T cell migration. Identification of a Rac GEF in our system would provide 
insight into T cell migration and circulation outside of an inflammatory environment, as well 
as novel targets for modulating T cell activity.  
Following antibody mediated crosslinking of CD4, we have identified the activation 
of an Lck independent pathway. We were unable to identify the direct downstream effector 
which results in activation of the signaling cascade. One method to determining the initiator 
of the signaling cascade would be utilizing a pulldown approach. Briefly, pulldown of the 
CD4 molecule in T cells isolated from YTS177 or isotype treated mice, followed by gel 
electrophoresis and silver staining could determine a unique protein band in CD4 crosslinked 
T cells. Identification of the unique molecule would be accomplished utilizing a mass 
spectrometry approach. Determining the direct downstream effector of CD4, as well as the 
GEF resulting in Rac activation would complete the identification of the signaling cascade, 
which provides a cellular mechanism for T cell migration in the absence of TCR activation.  
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Figure 11: A model for age dependent thymic production of autoreactive and colitogenic T cells. 
Incomplete thymic medullary structure and utilization of T cell precursors derived from embryonic liver 
result in reduced efficiency of negative selection and increased escape of autoreactive T cells up until day 10 
post birth. Better defined medulla and utilization of bone marrow derived thymocyte precursors in animals 
older than 10 days, results in increased efficiency of both negative and positive selection, resulting in 
reduced production of autoreactive T cells and increased production of T cells reactive to gut microbiota 
(colitogenic).  
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Figure 12. Model for altered T cell trafficking following YTS177 mediated crosslinking of CD4. 
CD4 crosslinking in lymph nodes results in downstream Rac1 and Rac2 activation independent of LCK, PI3K, 
and the Rac GEFs Tiam1, Dock2, Vav1, Vav2, and Trio. T cells then become polarized and exhibit a reduction 
in the lymph node retention molecule LFA-1 as well as the cell adhesion molecule CD62L. Increased 
sensitivity to S1P and chemokines results in lymph node egress where the reduction of cell adhesion 
molecules prevents re-entry into the lymphatics.  
 
 
Conclusion  
In summary, these studies provide new insight into events: i) that influence thymic 
development of autoreactive T cells, and ii) that regulate T cell migratory properties during 
an inflammatory response. These findings may be further exploited in the future to prevent 
and treat type 1 diabetes. Prevention of type 1 diabetes may be the most effective when 
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intervening with a given strategy in neonates found to be at high risk based on genotyping for 
instance.  In addition, the signaling pathway(s) engaged by CD4 crosslinking may provide 
new targets to selectively modify the migratory properties and block the pathogenicity of T 
cells mediating unwanted inflammatory responses.  
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Appendix  
 
Appendix 1. Diabetes development is unaffected by colitogenic T cells. 
Diabetes incidence (left) and colitis scores (right) for NOD.scid recipients of splenocytes (107) from diabetic 
NOD donors alone (n=3), or mixtures of diabetic splenocytes (107) plus splenocytes (107) from newborn 
(NB; n=5) or 4 wk (n=4) thymus transplant recipients (*p<0.02, 4wk thymus+diabetic splenocytes versus 
newborn thymus+diabetic splenocytes and diabetic splenocytes alone; Student’s t test). Error bars represent 
SEM. 
 
Appendix 2. Organ infiltration in NOD.scid recipients of 12 wk-old B6g7 thymi. 
Representative H&E stained sections from 12 wk-old WT B6g7 (right column) and NOD.scid recipients of 12 
wk-old B6g7 thymi (left column) 6 wks post engraftment. Arrows highlight areas of infiltration. 
.  
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